Context Capital Management »

Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Context Capital Management

Quarter-by-quarter ownership of Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Context Capital Management from 13F filings

Historical chart of Context Capital Management investment in Intercept Pharmaceuticals In Note 2.000 5/1 bnd

Tip: Access up to 7 years of quarterly data

All positions including Intercept Pharmaceuticals In Note 2.000 5/1 bnd held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intercept Pharmaceuticals In Note 2.000 5/1 bnd by Context Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $23M 23k 979.89
2023-06-30 $16M 20k 804.20
2023-03-31 $17M 20k 826.84
2022-12-31 $17M 23k 766.48
2022-09-30 $14M 19k 747.89
2022-06-30 $6.3M 9.8k 641.25
2021-03-31 $5.2M 8.0k 655.73
2020-12-31 $4.5M 7.5M 0.60
2020-09-30 $5.1M 7.5M 0.69
2020-06-30 $1.4M 2.0M 0.72
2020-03-31 $863k 985k 0.88
2019-12-31 $4.6M 3.5M 1.32
2019-09-30 $4.5M 5.0M 0.90
2019-06-30 $2.5M 2.5M 0.99

Top funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd